10 October 2012
British Pharmacological Society response to the 2012 Nobel Prize for Chemistry
26 September 2012
BPS member Professor Donald Singer blogs on a recent Independent article Cannabis use in teenagers and the long-term risk to IQ.
12 September 2012
BJCP press release
Drugs prescribed to treat anxiety, depression and insomnia may increase patients’ risk of being involved in motor vehicle accidents, according to a recent study, published in the British Journal of Clinical Pharmacology. Based on the findings, the researchers suggested doctors should consider advising patients not to drive while taking these drugs.
11 September 2012
The Scientific Programme Committee of the 17th World Congress on Basic and Clinical Pharmacology (WCP 2014), which will take place in Cape Town, South Africa from 13 to 18 July 2014, is inviting detailed proposals for sessions.
The deadline for submissions is Thursday 15 November 2012. Submitters will be informed of the outcome by mid-February 2013.
Detailed information is available on the congress website.
Please do not hesitate to contact the Congress Secretariat should you need any further information or have any questions, Carolyn Ackermann
Tel: +27 11 463 5085.
Please submit your proposals directly through the link provided. If you wish to hold your session under the aegis of BPS, or for it to be considered for BPS sponsorship, please send a copy of your proposal to the BPS office at the time of submission.
29 August 2012
This popular BPS Diploma in Advanced Pharmacology GART workshop, will develop and refresh knowledge of how common theories of drug action can be quantified and how simple receptor mechanisms can be used to interpret pharmacological data. The workshop considers both agonist and antagonist action and the interpretation of radioligand binding data, from basic mechanisms to clinical application, and is appropriate for anyone with a background in the biosciences and at least one or two years of experience of laboratory experiments.
07 August 2012
The British Pharmacological Society (BPS) welcomes the recently published Finch Report, and Government’s response to it, in supporting a transition to a sustainable open access publishing model. BPS recognizes the need to ensure peer reviewed research is available quickly, to enable the UK research community to stay at the forefront of scientific developments. The Society's response agrees with the principle that publicly funded research should be available to the public.
18 July 2012
The BPS Meetings Committee is seeking symposia proposals for Pharmacology 2013 (BPS Winter Meeting) which will be held from Tuesday 17 to Thursday 19 December 2013 at the Queen Elizabeth II Conference Centre in London. Please send your proposals including all the information listed below to the BPS office by Monday 8 October 2012:
• Title of symposium
• Four suggested speakers plus two reserves
When considering speakers for your proposal, please take into account the BPS Equality and Diversity Guidelines.
• Outline programme including likely presentation titles
• Potential audience profile
• Estimate of any likely output for BPS journals: BJP/BJCP
• Potential sources of sponsorship
We encourage all organizers to raise sponsorship for their symposia. The BPS office will be happy to assist with this.
16 July 2012
It is with sadness that we inform you of the death of Jack Botting. Jack was a man of considerable influence with a deep commitment to his students, and an extraordinary ability to stimulate their enthusiasm for pharmacology.
Jack's funeral will take place on Thursday 26 July at 3.15 at the South London Crematorium.
12 July 2012
The Home Office animal research statistics for 2011 present information about animal research in the UK such as the number of ‘procedures’ performed, what they were for, and who was doing them. Understanding Animal Research has analysed the information and released a statistics briefing.
23 May 2012
The Ethical Standards in Health and Life Sciences Group (ESHLSG) has today (23 May 2012) published a new series of Clinical Trial Transparency Principles and Facts.
This is the first time that leading healthcare professional bodies and senior representatives of the pharmaceutical industry have agreed to a joint approach on this critical issue. This is an important step forward in the on-going move across the entire research community to drive best practice in clinical research reporting.